
QSAM Biosciences, Inc.
OTC:QSAM
Overview | Financials
Company Name | QSAM Biosciences, Inc. |
Symbol | QSAM |
Currency | USD |
Price | 7 |
Market Cap | 23,015,580 |
Dividend Yield | 0% |
52-week-range | 3.51 - 7.5 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Douglas R. Baum |
Website | https://qsambio.com |
An error occurred while fetching data.
About QSAM Biosciences, Inc.
QSAM Biosciences, Inc. engages in developing various nuclear medicines for the treatment of cancer and related diseases. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage bone targeting radiopharmaceutical. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc.
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD